SINONASAL SQUAMOUS CELL CARCINOMA
Clinical trials for SINONASAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SINONASAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SINONASAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink hard-to-treat sinus cancers before surgery
Disease control Recruiting nowThis study is for people with a type of sinus cancer called sinonasal squamous cell carcinoma. It compares standard chemotherapy alone to chemotherapy plus an immunotherapy drug (cemiplimab) given before surgery. The goal is to see if adding immunotherapy helps shrink tumors more…
Matched conditions: SINONASAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:04 UTC
-
New combo aims to shrink head and neck tumors, sparing patients from radical surgery
Disease control Recruiting nowThis study tests giving chemotherapy and immunotherapy before standard surgery for head and neck cancer. The goal is to shrink tumors enough so that surgeons can do a less extensive operation, preserving speech, swallowing, and vision. About 75 adults with newly diagnosed, advanc…
Matched conditions: SINONASAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 11:00 UTC